Sunshine Biopharma Inc.
SBFM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001402328
No open-market purchases or sales by Sunshine Biopharma Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $32.6K in total; no superinvestor holds it.
Other share classesSBFMW
13F holders, Q3 2022
Institutional positions in Sunshine Biopharma Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 12
- −6 vs. Q2 2022
- Shares held
- 429.4K
- −308.0K (−41.8%) vs. Q2 2022
- Total value
- $341.1K
- −$461.0K (−57.5%) vs. Q2 2022
- New holders
- 2
- 1 more added
- Sold out
- 8
- 4 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SBFM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 9 | $32.6K |
| Q1 2026 | 12 | $127.1K |
| Q4 2025 | 13 | $141.7K |
| Q3 2025 | 14 | $337.3K |
| Q2 2025 | 12 | $187.2K |
| Q1 2025 | 11 | $151.7K |
| Q4 2024 | 12 | $61.8K |
| Q3 2024 | 10 | $111.3K |
| Q2 2024 | 11 | $89.6K |
| Q1 2024 | 15 | $346.2K |
| Q4 2023 | 15 | $745.7K |
| Q3 2023 | 11 | $415.1K |
| Q2 2023 | 10 | $1.25M |
| Q1 2023 | 13 | $292.4K |
| Q4 2022 | 12 | $261.8K |
| Q3 2022 | 12 | $341.1K |
| Q2 2022 | 18 | $802.1K |
| Q1 2022 | 13 | $3.55M |
| Q4 2021 | 1 | $17.0K |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Sunshine Biopharma Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bridgeway Capital Management, LLC | 286,100 | $221.0K | 0.01% | −282,300−49.7% | Reduced |
| Bank of Montreal | 30,000 | $33.0K | 0.00% | −1,000−3.2% | Reduced |
| Two Sigma Investments, LP | 37,386 | $29.0K | 0.00% | +37,386 | New |
| Geode Capital Management, LLC | 20,179 | $15.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 16,846 | $13.0K | 0.00% | −3,876−18.7% | Reduced |
| Bank of America Corp | 17,019 | $13.0K | 0.00% | +13,689+411.1% | Added |
| Susquehanna International Group, LLP | 13,849 | $11.0K | 0.00% | +13,849 | New |
| Advisor Group Holdings, Inc. | 6,628 | $5.00K | 0.00% | −900−12.0% | Reduced |
| National Bank of Canada | 1,042 | $1.00K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 79 | $61 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Rise Advisors, LLC | 293 | $0 | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 0 | $0 | 0.00% | −47,861−100.0% | Sold out |
| Dakota Wealth Management | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −8,128−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −6,867−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −1,464−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −130−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Larson Financial Group LLC | 0 | $0 | 0.00% | −127−100.0% | Sold out |